SIMILAR PATTERNS OF AMINO ACIDS FOR 2VCV_D_ASDD1224
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bsg | BETA LACTAMASE (Streptomycesalbus) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.24A | 2vcvD-1bsgA:0.0 | 2vcvD-1bsgA:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bta | BARSTAR (Bacillusamyloliquefaciens) |
PF01337(Barstar) | 5 | LEU A 16LEU A 37LEU A 24ALA A 3PHE A 74 | None | 1.09A | 2vcvD-1btaA:undetectable | 2vcvD-1btaA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dkd | GROEL (Escherichiacoli) |
PF00118(Cpn60_TCP1) | 5 | LEU A 221LEU A 237ALA A 275LEU A 262ALA A 258 | None | 1.18A | 2vcvD-1dkdA:0.5 | 2vcvD-1dkdA:23.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1dpb | DIHYDROLIPOYL-TRANSACETYLASE (Azotobactervinelandii) |
PF00198(2-oxoacid_dh) | 5 | PRO A 468LEU A 469ALA A 530LEU A 526PHE A 449 | None | 0.99A | 2vcvD-1dpbA:undetectable | 2vcvD-1dpbA:23.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ebv | PROSTAGLANDIN H2SYNTHASE (Ovis aries) |
PF00008(EGF)PF03098(An_peroxidase) | 5 | PHE A 478PRO A 172LEU A 177LEU A 494PHE A 181 | None | 1.10A | 2vcvD-1ebvA:0.3 | 2vcvD-1ebvA:16.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f0x | D-LACTATEDEHYDROGENASE (Escherichiacoli) |
PF01565(FAD_binding_4)PF09330(Lact-deh-memb) | 5 | PRO A 199LEU A 203LEU A 187ALA A 177PHE A 263 | None | 0.99A | 2vcvD-1f0xA:0.0 | 2vcvD-1f0xA:17.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g68 | BETA-LACTAMASE PSE-4 (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.11A | 2vcvD-1g68A:0.0 | 2vcvD-1g68A:23.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gxs | P-(S)-HYDROXYMANDELONITRILE LYASE CHAINA (Sorghum bicolor) |
PF00450(Peptidase_S10) | 5 | LEU A 13PRO A 17LEU A 91ALA A 79PHE A 22 | None | 1.08A | 2vcvD-1gxsA:0.0 | 2vcvD-1gxsA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1h2t | 80 KDA NUCLEAR CAPBINDING PROTEIN (Homo sapiens) |
PF02854(MIF4G)PF09088(MIF4G_like)PF09090(MIF4G_like_2) | 5 | PHE C 292LEU C 376LEU C 391ALA C 394PHE C 356 | None | 1.18A | 2vcvD-1h2tC:2.2 | 2vcvD-1h2tC:17.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1htj | KIAA0380 (Homo sapiens) |
PF09128(RGS-like) | 5 | LEU F 383LEU F 369ALA F 397ALA F 346PHE F 342 | None | 0.99A | 2vcvD-1htjF:undetectable | 2vcvD-1htjF:22.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ihm | CAPSID PROTEIN (Norwalk virus) |
PF00915(Calici_coat)PF08435(Calici_coat_C) | 5 | LEU A1437LEU A1233LEU A1459ALA A1457PHE A1231 | None | 1.24A | 2vcvD-1ihmA:undetectable | 2vcvD-1ihmA:17.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1izo | CYTOCHROME P450152A1 (Bacillussubtilis) |
PF00067(p450) | 5 | LEU A 251LEU A 377LEU A 258ALA A 257PHE A 279 | None | 1.24A | 2vcvD-1izoA:undetectable | 2vcvD-1izoA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1k1b | B-CELL LYMPHOMA3-ENCODED PROTEIN (Homo sapiens) |
PF00023(Ank)PF12796(Ank_2) | 5 | LEU A 281LEU A 288ALA A 275LEU A 272ALA A 304 | None | 1.09A | 2vcvD-1k1bA:undetectable | 2vcvD-1k1bA:25.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ka9 | IMIDAZOLE GLYCEROLPHOSPHATE SYNTHASE (Thermusthermophilus) |
PF00117(GATase) | 5 | PRO H 175LEU H 166LEU H 173ALA H 193PHE H 130 | None | 1.14A | 2vcvD-1ka9H:undetectable | 2vcvD-1ka9H:24.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1la1 | GROEL (Escherichiacoli) |
PF00118(Cpn60_TCP1) | 5 | LEU A 221LEU A 237ALA A 275LEU A 262ALA A 258 | None | 1.07A | 2vcvD-1la1A:undetectable | 2vcvD-1la1A:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1m66 | GLYCEROL-3-PHOSPHATEDEHYDROGENASE (Leishmaniamexicana) |
PF01210(NAD_Gly3P_dh_N)PF07479(NAD_Gly3P_dh_C) | 5 | LEU A 339LEU A 321ALA A 220LEU A 233ALA A 232 | PLM A 402 ( 4.9A)NonePLM A 402 ( 4.0A)PLM A 402 ( 4.3A)PLM A 402 ( 4.0A) | 1.21A | 2vcvD-1m66A:undetectable | 2vcvD-1m66A:21.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n9b | BETA-LACTAMASE SHV-2 (Klebsiellapneumoniae) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.05A | 2vcvD-1n9bA:undetectable | 2vcvD-1n9bA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pxt | PEROXISOMAL3-KETOACYL-COATHIOLASE (Saccharomycescerevisiae) |
PF00108(Thiolase_N)PF02803(Thiolase_C) | 5 | LEU A 285LEU A 148ALA A 131LEU A 150ALA A 281 | None | 1.18A | 2vcvD-1pxtA:undetectable | 2vcvD-1pxtA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q15 | CARA (Pectobacteriumcarotovorum) |
PF00733(Asn_synthase)PF09147(DUF1933) | 5 | LEU A 231LEU A 227ALA A 256LEU A 253PHE A 397 | None | 1.21A | 2vcvD-1q15A:undetectable | 2vcvD-1q15A:19.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vki | HYPOTHETICAL PROTEINATU3699 (Agrobacteriumfabrum) |
PF04073(tRNA_edit) | 5 | LEU A 16LEU A 151ALA A 157LEU A 155ALA A 111 | None | 1.13A | 2vcvD-1vkiA:undetectable | 2vcvD-1vkiA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1w0m | TRIOSEPHOSPHATEISOMERASE (Thermoproteustenax) |
PF00121(TIM)PF05690(ThiG) | 5 | LEU A 218PRO A 221LEU A 222LEU A 192ALA A 191 | None | 1.18A | 2vcvD-1w0mA:undetectable | 2vcvD-1w0mA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wv9 | RHODANESE HOMOLOGTT1651 (Thermusthermophilus) |
no annotation | 5 | PRO A 6LEU A 9ALA A 89LEU A 83PHE A 34 | None | 1.21A | 2vcvD-1wv9A:undetectable | 2vcvD-1wv9A:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z7z | HUMAN COXSACKIEVIRUSA21 (Enterovirus C) |
PF00073(Rhv) | 5 | PRO 3 88LEU 3 94LEU 3 86ALA 3 167PHE 3 115 | None | 1.24A | 2vcvD-1z7z3:undetectable | 2vcvD-1z7z3:19.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zg4 | BETA-LACTAMASE TEM (Escherichiacoli) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.05A | 2vcvD-1zg4A:undetectable | 2vcvD-1zg4A:20.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a8x | DIHYDROLIPOYLDEHYDROGENASE (Mycobacteriumtuberculosis) |
PF02852(Pyr_redox_dim)PF07992(Pyr_redox_2) | 5 | PHE A 350LEU A 316PRO A 346LEU A 420ALA A 417 | FAD A 480 ( 4.8A)FAD A 480 (-3.7A)NoneNoneNone | 1.22A | 2vcvD-2a8xA:undetectable | 2vcvD-2a8xA:18.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2azk | GERANYLGERANYLPYROPHOSPHATESYNTHETASE (Sulfolobussolfataricus) |
PF00348(polyprenyl_synt) | 5 | LEU A 186LEU A 167ALA A 173LEU A 171ALA A 128 | None | 1.20A | 2vcvD-2azkA:2.1 | 2vcvD-2azkA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b3t | PROTEINMETHYLTRANSFERASEHEMK (Escherichiacoli) |
PF13847(Methyltransf_31) | 6 | TYR A 255LEU A 236LEU A 116LEU A 114ALA A 227PHE A 169 | None | 1.37A | 2vcvD-2b3tA:undetectable | 2vcvD-2b3tA:18.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bgh | VINORINE SYNTHASE (Rauvolfiaserpentina) |
PF02458(Transferase) | 5 | PHE A 221LEU A 348LEU A 397ALA A 395PHE A 350 | None | 1.11A | 2vcvD-2bghA:undetectable | 2vcvD-2bghA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cc1 | BETA-LACTAMASE (Mycolicibacteriumfortuitum) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.18A | 2vcvD-2cc1A:undetectable | 2vcvD-2cc1A:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ch1 | 3-HYDROXYKYNURENINETRANSAMINASE (Anophelesgambiae) |
PF00266(Aminotran_5) | 5 | PRO A 215LEU A 60ALA A 203LEU A 268ALA A 271 | None | 1.22A | 2vcvD-2ch1A:undetectable | 2vcvD-2ch1A:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dou | PROBABLEN-SUCCINYLDIAMINOPIMELATEAMINOTRANSFERASE (Thermusthermophilus) |
PF00155(Aminotran_1_2) | 5 | LEU A 357LEU A 361ALA A 367LEU A 365ALA A 299 | NoneSO4 A 502 (-4.3A)NoneNoneNone | 0.99A | 2vcvD-2douA:undetectable | 2vcvD-2douA:22.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fqz | R.ECL18KI (Enterobactercloacae) |
PF09019(EcoRII-C) | 5 | TYR A 295LEU A 161ALA A 255LEU A 252ALA A 135 | None | 1.20A | 2vcvD-2fqzA:1.3 | 2vcvD-2fqzA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ivf | ETHYLBENZENEDEHYDROGENASEGAMMA-SUBUNIT (Aromatoleumaromaticum) |
PF09459(EB_dh) | 5 | PHE C 187LEU C 177ALA C 62ALA C 95PHE C 97 | None | 1.12A | 2vcvD-2ivfC:undetectable | 2vcvD-2ivfC:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2l6b | NR1C (Escherichiacoli) |
PF12796(Ank_2) | 5 | PRO A 78LEU A 94ALA A 70LEU A 46ALA A 66 | None | 1.21A | 2vcvD-2l6bA:undetectable | 2vcvD-2l6bA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oq5 | TRANSMEMBRANEPROTEASE, SERINE 11E (Homo sapiens) |
PF00089(Trypsin) | 5 | LEU A 46ALA A 106LEU A 108ALA A 66PHE A 68 | None | 1.20A | 2vcvD-2oq5A:undetectable | 2vcvD-2oq5A:19.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p1r | LIPID KINASE YEGS (Salmonellaenterica) |
PF00781(DAGK_cat) | 5 | PRO A 92LEU A 93ALA A 112LEU A 109ALA A 24 | None | 1.22A | 2vcvD-2p1rA:undetectable | 2vcvD-2p1rA:23.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p2w | CITRATE SYNTHASE (Thermotogamaritima) |
PF00285(Citrate_synt) | 5 | LEU A 98ALA A 202LEU A 203ALA A 322PHE A 122 | None | 1.02A | 2vcvD-2p2wA:undetectable | 2vcvD-2p2wA:21.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p2w | CITRATE SYNTHASE (Thermotogamaritima) |
PF00285(Citrate_synt) | 5 | LEU A 195LEU A 98ALA A 202LEU A 203PHE A 122 | None | 1.05A | 2vcvD-2p2wA:undetectable | 2vcvD-2p2wA:21.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p90 | HYPOTHETICAL PROTEINCGL1923 (Corynebacteriumglutamicum) |
PF09754(PAC2) | 5 | PRO A 110LEU A 91LEU A 32ALA A 179PHE A 119 | None | 1.20A | 2vcvD-2p90A:undetectable | 2vcvD-2p90A:22.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r7d | RIBONUCLEASE IIFAMILY PROTEIN (Deinococcusradiodurans) |
PF00773(RNB) | 5 | PHE A 75PRO A 341LEU A 348ALA A 121ALA A 125 | None | 0.89A | 2vcvD-2r7dA:undetectable | 2vcvD-2r7dA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x66 | PRNB (Pseudomonasfluorescens) |
PF08933(DUF1864) | 5 | LEU A 279LEU A 299ALA A 273LEU A 236PHE A 303 | None | 1.24A | 2vcvD-2x66A:3.7 | 2vcvD-2x66A:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xry | DEOXYRIBODIPYRIMIDINE PHOTOLYASE (Methanosarcinamazei) |
PF00875(DNA_photolyase) | 5 | LEU A 396PRO A 392LEU A 386LEU A 333ALA A 329 | None | 1.13A | 2vcvD-2xryA:undetectable | 2vcvD-2xryA:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zhy | ATP:COB(I)ALAMINADENOSYLTRANSFERASE,PUTATIVE (Burkholderiathailandensis) |
PF01923(Cob_adeno_trans) | 5 | PRO A 55LEU A 54ALA A 169LEU A 166ALA A 115 | None | 1.16A | 2vcvD-2zhyA:undetectable | 2vcvD-2zhyA:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aoe | GLUTAMATEDEHYDROGENASE (Thermusthermophilus) |
no annotation | 5 | LEU E 293ALA E 296LEU E 295ALA E 301PHE E 286 | None | 1.14A | 2vcvD-3aoeE:undetectable | 2vcvD-3aoeE:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aq2 | 6B PROTEIN (Agrobacteriumvitis) |
PF02027(RolB_RolC) | 5 | LEU A 20ALA A 27LEU A 24ALA A 133PHE A 131 | None | 1.09A | 2vcvD-3aq2A:undetectable | 2vcvD-3aq2A:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cfz | UPF0100 PROTEINMJ1186 (Methanocaldococcusjannaschii) |
PF13531(SBP_bac_11) | 5 | PRO A 51LEU A 317LEU A 48ALA A 93PHE A 115 | None | 1.13A | 2vcvD-3cfzA:undetectable | 2vcvD-3cfzA:23.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cij | UPF0100 PROTEINAF_0094 (Archaeoglobusfulgidus) |
PF13531(SBP_bac_11) | 5 | PRO A 46LEU A 315LEU A 43ALA A 88PHE A 110 | None | 1.18A | 2vcvD-3cijA:undetectable | 2vcvD-3cijA:23.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3cou | NUCLEOSIDEDIPHOSPHATE-LINKEDMOIETY X MOTIF 16 (Homo sapiens) |
PF00293(NUDIX) | 5 | LEU A 46PRO A 58LEU A 77ALA A 85PHE A 88 | None | 1.06A | 2vcvD-3couA:undetectable | 2vcvD-3couA:23.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fj7 | MAJOR ANTIGENICPEPTIDE PEB3 (Campylobacterjejuni) |
PF13531(SBP_bac_11) | 5 | LEU A 234ALA A 33LEU A 34ALA A 38PHE A 230 | None | 1.23A | 2vcvD-3fj7A:undetectable | 2vcvD-3fj7A:21.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hfw | PROTEINADP-RIBOSYLARGININEHYDROLASE (Homo sapiens) |
PF03747(ADP_ribosyl_GH) | 5 | LEU A 292LEU A 43ALA A 307LEU A 17ALA A 13 | None CL A 360 (-4.7A)NoneNoneNone | 1.22A | 2vcvD-3hfwA:undetectable | 2vcvD-3hfwA:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iu1 | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE 1 (Homo sapiens) |
PF01233(NMT)PF02799(NMT_C) | 5 | TYR A 401LEU A 176LEU A 197ALA A 200PHE A 247 | None | 1.20A | 2vcvD-3iu1A:undetectable | 2vcvD-3iu1A:21.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jab | GAFB DOMAIN OFPHOSPHODIESTERASE 2A (Bos taurus) |
PF01590(GAF) | 5 | PHE B 505LEU B 403LEU B 414ALA B 421ALA B 518 | None | 1.17A | 2vcvD-3jabB:3.2 | 2vcvD-3jabB:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kio | RIBONUCLEASE H2SUBUNIT C (Mus musculus) |
PF08615(RNase_H2_suC) | 5 | PRO C 33LEU C 32LEU C 68ALA C 61PHE C 48 | None | 1.20A | 2vcvD-3kioC:undetectable | 2vcvD-3kioC:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mkr | COATOMER SUBUNITALPHA (Bos taurus) |
PF06957(COPI_C) | 5 | LEU B1034PRO B1037LEU B1038LEU B 943PHE B 959 | None | 1.09A | 2vcvD-3mkrB:2.3 | 2vcvD-3mkrB:20.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nog | DESIGNED ANKYRINREPEAT PROTEIN (syntheticconstruct) |
PF00023(Ank)PF12796(Ank_2) | 5 | LEU D 126LEU D 133ALA D 120LEU D 117ALA D 149 | None | 1.10A | 2vcvD-3nogD:undetectable | 2vcvD-3nogD:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3o8l | 6-PHOSPHOFRUCTOKINASE, MUSCLE TYPE (Oryctolaguscuniculus) |
PF00365(PFK) | 5 | LEU A 136LEU A 156LEU A 105ALA A 101PHE A 128 | None | 1.24A | 2vcvD-3o8lA:undetectable | 2vcvD-3o8lA:15.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p1t | PUTATIVEHISTIDINOL-PHOSPHATEAMINOTRANSFERASE (Burkholderiapseudomallei) |
PF00155(Aminotran_1_2) | 5 | PHE A 210LEU A 236LEU A 72ALA A 208PHE A 195 | None | 1.19A | 2vcvD-3p1tA:undetectable | 2vcvD-3p1tA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p3q | MMOQ (Methylococcuscapsulatus) |
PF08668(HDOD) | 5 | LEU A 207PRO A 213ALA A 87ALA A 153PHE A 237 | None | 1.10A | 2vcvD-3p3qA:undetectable | 2vcvD-3p3qA:25.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3psh | PROTEIN HI_1472 (Haemophilusinfluenzae) |
PF01497(Peripla_BP_2) | 5 | TYR A 340LEU A 181LEU A 161LEU A 307ALA A 306 | None | 1.19A | 2vcvD-3pshA:undetectable | 2vcvD-3pshA:20.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q9d | PROTEINCPN_0803/CP_1068/CPJ0803/CPB0832 (Chlamydiapneumoniae) |
PF17435(DUF5414) | 5 | LEU A 18LEU A 10ALA A 76LEU A 69PHE A 55 | None | 1.20A | 2vcvD-3q9dA:3.2 | 2vcvD-3q9dA:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qxz | ENOYL-COAHYDRATASE/ISOMERASE (Mycobacteroidesabscessus) |
PF00378(ECH_1) | 5 | TYR A 127LEU A 18ALA A 100LEU A 53ALA A 113 | None | 1.16A | 2vcvD-3qxzA:undetectable | 2vcvD-3qxzA:21.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3re1 | UROPORPHYRINOGEN-IIISYNTHETASE (Pseudomonassyringae groupgenomosp. 3) |
PF02602(HEM4) | 5 | LEU A 18LEU A 6LEU A 247ALA A 246PHE A 214 | None | 1.22A | 2vcvD-3re1A:undetectable | 2vcvD-3re1A:25.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sir | CASPASE (Drosophilamelanogaster) |
PF00656(Peptidase_C14) | 5 | PHE A 58LEU A 253LEU A 215LEU A 202PHE A 134 | None | 1.23A | 2vcvD-3sirA:undetectable | 2vcvD-3sirA:22.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tix | CHROMODOMAIN-CONTAININGPROTEIN 1 (Schizosaccharomycespombe) |
no annotation | 5 | PHE B 734LEU B 743LEU B 757ALA B 760PHE B 767 | None | 1.09A | 2vcvD-3tixB:undetectable | 2vcvD-3tixB:20.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ubr | CYTOCHROME C-552 (Shewanellaoneidensis) |
PF02335(Cytochrom_C552) | 5 | LEU A 75LEU A 247ALA A 82LEU A 437ALA A 433 | None | 1.11A | 2vcvD-3ubrA:undetectable | 2vcvD-3ubrA:17.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vu2 | 1,4-ALPHA-GLUCAN-BRANCHING ENZYME,CHLOROPLASTIC/AMYLOPLASTIC (Oryza sativa) |
PF00128(Alpha-amylase)PF02806(Alpha-amylase_C)PF02922(CBM_48) | 5 | LEU A 265LEU A 256LEU A 221ALA A 186PHE A 203 | None | 1.01A | 2vcvD-3vu2A:undetectable | 2vcvD-3vu2A:16.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zdj | ENCA BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.05A | 2vcvD-3zdjA:undetectable | 2vcvD-3zdjA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c2x | GLYCYLPEPTIDEN-TETRADECANOYLTRANSFERASE 2 (Homo sapiens) |
PF01233(NMT)PF02799(NMT_C) | 5 | TYR A 401LEU A 176LEU A 197ALA A 200PHE A 247 | None | 1.22A | 2vcvD-4c2xA:undetectable | 2vcvD-4c2xA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c6y | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.14A | 2vcvD-4c6yA:undetectable | 2vcvD-4c6yA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c75 | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.13A | 2vcvD-4c75A:undetectable | 2vcvD-4c75A:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ev4 | CARBAPENEM-HYDROLIZING BETA-LACTAMASESFC-1 (Serratiafonticola) |
PF13354(Beta-lactamase2) | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.03A | 2vcvD-4ev4A:undetectable | 2vcvD-4ev4A:23.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ezi | UNCHARACTERIZEDPROTEIN (Legionellapneumophila) |
no annotation | 6 | PRO A 222LEU A 336ALA A 225LEU A 338ALA A 355PHE A 359 | None | 1.37A | 2vcvD-4eziA:undetectable | 2vcvD-4eziA:22.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fdd | TRANSPORTIN-1 (Homo sapiens) |
PF03810(IBN_N)PF13513(HEAT_EZ) | 5 | TYR A 465LEU A 395ALA A 387LEU A 383ALA A 423 | None | 1.12A | 2vcvD-4fddA:3.4 | 2vcvD-4fddA:15.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g9s | INHIBITOR OF G-TYPELYSOZYME (Escherichiacoli) |
PF04151(PPC) | 5 | LEU B 75ALA B 103LEU B 101ALA B 56PHE B 54 | None | 1.23A | 2vcvD-4g9sB:undetectable | 2vcvD-4g9sB:23.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4giw | RUN AND SH3DOMAIN-CONTAININGPROTEIN 1 (Homo sapiens) |
PF02759(RUN) | 5 | LEU A 12LEU A 175ALA A 58LEU A 59PHE A 137 | None | 1.24A | 2vcvD-4giwA:undetectable | 2vcvD-4giwA:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glx | DNA LIGASE (Escherichiacoli) |
PF01653(DNA_ligase_aden)PF03119(DNA_ligase_ZBD)PF03120(DNA_ligase_OB)PF12826(HHH_2)PF14520(HHH_5) | 5 | LEU A 576LEU A 535ALA A 514LEU A 512PHE A 564 | None | 1.24A | 2vcvD-4glxA:2.5 | 2vcvD-4glxA:16.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hj2 | GLUTATHIONES-TRANSFERASE A1 (Homo sapiens) |
PF00043(GST_C)PF02798(GST_N) | 6 | TYR A 9PHE A 10LEU A 107PRO A 110LEU A 213ALA A 216 | LZ6 A 301 (-4.6A)NoneLZ6 A 301 (-4.4A)LZ6 A 301 (-3.5A)NoneLZ6 A 301 ( 4.6A) | 0.79A | 2vcvD-4hj2A:36.5 | 2vcvD-4hj2A:90.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hyq | PHOSPHOLIPASE A1 (Streptomycesalbidoflavus) |
PF13472(Lipase_GDSL_2) | 5 | PHE A 48LEU A 229LEU A 140ALA A 34ALA A 7 | None | 1.14A | 2vcvD-4hyqA:undetectable | 2vcvD-4hyqA:24.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ia5 | MYOSIN-CROSSREACTIVEANTIGEN (Lactobacillusacidophilus) |
PF06100(MCRA) | 5 | PHE A 178LEU A 194ALA A 201LEU A 152PHE A 169 | None | 1.20A | 2vcvD-4ia5A:1.0 | 2vcvD-4ia5A:18.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l87 | SERINE--TRNA LIGASE,CYTOPLASMIC (Homo sapiens) |
PF00587(tRNA-synt_2b)PF02403(Seryl_tRNA_N) | 5 | LEU A 355ALA A 206LEU A 207ALA A 211PHE A 351 | None | 1.17A | 2vcvD-4l87A:undetectable | 2vcvD-4l87A:19.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m2j | AMINOTRANSFERASE (Streptomyceslavendulae) |
PF00155(Aminotran_1_2) | 5 | LEU A 291LEU A 375LEU A 345ALA A 357PHE A 317 | None | 1.12A | 2vcvD-4m2jA:undetectable | 2vcvD-4m2jA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mll | BETA-LACTAMASE OXA-1 (Escherichiacoli) |
PF00905(Transpeptidase) | 5 | PHE A 69LEU A 184LEU A 75ALA A 72PHE A 175 | None | 1.20A | 2vcvD-4mllA:undetectable | 2vcvD-4mllA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n78 | CYTOPLASMICFMR1-INTERACTINGPROTEIN 1 (Homo sapiens) |
PF05994(FragX_IP)PF07159(DUF1394) | 5 | PHE A 359LEU A 612LEU A 255ALA A 394LEU A 395 | None | 1.17A | 2vcvD-4n78A:4.5 | 2vcvD-4n78A:11.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wxb | SERINEHYDROXYMETHYLTRANSFERASE (Streptococcusthermophilus) |
PF00464(SHMT) | 5 | PHE A 277LEU A 233ALA A 268LEU A 269PHE A 80 | None | 1.24A | 2vcvD-4wxbA:0.8 | 2vcvD-4wxbA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xaj | MALTOSE-BINDINGPERIPLASMICPROTEIN,NUCLEARRECEPTOR SUBFAMILY 2GROUP E MEMBER 1 (Escherichiacoli;Homo sapiens) |
PF00104(Hormone_recep)PF13416(SBP_bac_8) | 5 | LEU A1346LEU A1288LEU A1228ALA A1231PHE A1285 | None | 1.21A | 2vcvD-4xajA:undetectable | 2vcvD-4xajA:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aqa | OFF7_DB04V3 (syntheticconstruct) |
PF00023(Ank)PF12796(Ank_2)PF13354(Beta-lactamase2) | 5 | PRO A 275LEU A 292LEU A 269ALA A 265PHE A 202 | None | 1.08A | 2vcvD-5aqaA:undetectable | 2vcvD-5aqaA:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cdk | CHAPERONIN 60B1 (Chlamydomonasreinhardtii) |
PF00118(Cpn60_TCP1) | 5 | LEU A 29LEU A 45ALA A 83LEU A 70ALA A 66 | None | 1.10A | 2vcvD-5cdkA:undetectable | 2vcvD-5cdkA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e43 | BETA-LACTAMASE (Streptosporangiumroseum) |
PF13354(Beta-lactamase2) | 5 | PRO A 146LEU A 163LEU A 140ALA A 136PHE A 72 | None | 1.05A | 2vcvD-5e43A:undetectable | 2vcvD-5e43A:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eoe | BETA-LACTAMASE (Pseudomonasaeruginosa) |
PF13354(Beta-lactamase2) | 5 | PRO A 138LEU A 155LEU A 132ALA A 128PHE A 64 | None | 1.15A | 2vcvD-5eoeA:undetectable | 2vcvD-5eoeA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ja1 | ENTEROBACTINBIOSYNTHESIS PROTEINYBDZENTEROBACTINSYNTHASE COMPONENT F (Escherichiacoli) |
PF00501(AMP-binding)PF00550(PP-binding)PF00668(Condensation)PF00975(Thioesterase)PF03621(MbtH)PF13193(AMP-binding_C) | 5 | PHE B 7PRO B 34LEU B 33ALA A 826LEU B 17 | None | 1.17A | 2vcvD-5ja1B:undetectable | 2vcvD-5ja1B:17.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k1b | WD REPEAT-CONTAININGPROTEIN 48 (Homo sapiens) |
PF00400(WD40)PF11816(DUF3337) | 5 | LEU B 460LEU B 390LEU B 466ALA B 469PHE B 507 | None | 1.22A | 2vcvD-5k1bB:undetectable | 2vcvD-5k1bB:14.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ll7 | BETA-LACTAMASE (Escherichiacoli) |
no annotation | 5 | PRO A 145LEU A 162LEU A 139ALA A 135PHE A 72 | None | 1.13A | 2vcvD-5ll7A:undetectable | 2vcvD-5ll7A:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nug | CYTOPLASMIC DYNEIN 1HEAVY CHAIN 1 (Homo sapiens) |
PF03028(Dynein_heavy)PF07728(AAA_5)PF08393(DHC_N2)PF12774(AAA_6)PF12775(AAA_7)PF12777(MT)PF12780(AAA_8)PF12781(AAA_9) | 5 | LEU A4042PRO A4040LEU A4124ALA A4141LEU A4113 | None | 1.04A | 2vcvD-5nugA:undetectable | 2vcvD-5nugA:3.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ti8 | AMINOTRANSFERASE (Pseudomonas sp.M1) |
PF00202(Aminotran_3) | 5 | LEU A 445PRO A 369LEU A 453ALA A 452PHE A 395 | None | 1.24A | 2vcvD-5ti8A:undetectable | 2vcvD-5ti8A:18.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uhe | DNA-DIRECTED RNAPOLYMERASE SUBUNITBETA' (Mycobacteriumtuberculosis) |
PF00623(RNA_pol_Rpb1_2)PF04983(RNA_pol_Rpb1_3)PF04997(RNA_pol_Rpb1_1)PF04998(RNA_pol_Rpb1_5)PF05000(RNA_pol_Rpb1_4) | 5 | PRO D 546LEU D 545ALA D 551LEU D 547PHE D 455 | None | 1.11A | 2vcvD-5uheD:undetectable | 2vcvD-5uheD:10.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5um8 | GLYCOPROTEIN GP120 (Humanimmunodeficiencyvirus 1) |
PF00516(GP120) | 5 | LEU G 122LEU G 193ALA G 161ALA G 174PHE G 176 | None | 1.16A | 2vcvD-5um8G:undetectable | 2vcvD-5um8G:17.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w0s | 60 KDA CHAPERONIN (Escherichiacoli) |
PF00118(Cpn60_TCP1) | 5 | LEU A 221LEU A 237ALA A 275LEU A 262ALA A 258 | None | 1.03A | 2vcvD-5w0sA:undetectable | 2vcvD-5w0sA:16.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xpg | UNCHARACTERIZEDPROTEIN (Thermusthermophilus) |
no annotation | 5 | PHE A 163LEU A 24PRO A 26LEU A 112ALA A 113 | None | 1.21A | 2vcvD-5xpgA:undetectable | 2vcvD-5xpgA:16.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6blj | SERINE-TRNA LIGASE (Naegleriafowleri) |
no annotation | 5 | LEU A 359ALA A 219LEU A 220ALA A 224PHE A 355 | None | 1.08A | 2vcvD-6bljA:undetectable | 2vcvD-6bljA:13.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6co7 | PREDICTED PROTEIN (Nematostellavectensis) |
no annotation | 5 | PHE A 644LEU A 581ALA A 587LEU A 585ALA A 613 | None | 1.08A | 2vcvD-6co7A:undetectable | 2vcvD-6co7A:17.21 |